Can MAPK pathways be targeted for therapeutic interventions?
Yes, MAPK pathways are potential targets for therapeutic interventions in diseases where these pathways are dysregulated, such as cancer and inflammatory diseases. In toxicology, modulating MAPK pathways could mitigate the harmful effects of toxic exposures. For instance, inhibitors of the p38 MAPK pathway are being explored as potential treatments for inflammatory conditions triggered by environmental pollutants.
